10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...
2 Reasons to Sell TXG and 1 Stock to Buy Instead
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Rating of “Hold” from Analysts
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...
Nasdaq27d
Insider Purchase: Director at $TXG Buys 40,000 Shares
ALAN MATEO, a director at $TXG, bought 40,000 shares of the company on 02-21-2025 for an estimated $445,572. This trade was reported by Quiver Quantitative using data ...
Yahoo Finance1mon
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
10x Genomics secures injunction against Parse Biosciences’ planned ATAC products
Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in ...
Has Torex Gold Resources Inc.'s (TSE:TXG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Most readers would already be aware that Torex Gold Resources' (TSE:TXG) stock increased significantly by 33% over ...